SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 305 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.70 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $22,000 | -4.3% | 300 | 0.0% | 0.01% | +14.3% |
| Q1 2022 | $23,000 | -14.8% | 300 | 0.0% | 0.01% | -12.5% |
| Q4 2021 | $27,000 | -3.6% | 300 | 0.0% | 0.01% | 0.0% |
| Q3 2021 | $28,000 | +21.7% | 300 | 0.0% | 0.01% | +14.3% |
| Q2 2021 | $23,000 | +4.5% | 300 | 0.0% | 0.01% | 0.0% |
| Q1 2021 | $22,000 | -56.9% | 300 | 0.0% | 0.01% | -58.8% |
| Q4 2020 | $51,000 | +21.4% | 300 | 0.0% | 0.02% | +6.2% |
| Q3 2020 | $42,000 | -12.5% | 300 | 0.0% | 0.02% | -20.0% |
| Q2 2020 | $48,000 | +65.5% | 300 | 0.0% | 0.02% | +33.3% |
| Q1 2020 | $29,000 | -23.7% | 300 | 0.0% | 0.02% | -11.8% |
| Q4 2019 | $38,000 | +65.2% | 300 | 0.0% | 0.02% | +41.7% |
| Q3 2019 | $23,000 | -50.0% | 300 | 0.0% | 0.01% | -50.0% |
| Q2 2019 | $46,000 | -23.3% | 300 | -40.0% | 0.02% | -22.6% |
| Q1 2019 | $60,000 | +11.1% | 500 | 0.0% | 0.03% | -3.1% |
| Q4 2018 | $54,000 | -33.3% | 500 | 0.0% | 0.03% | -25.6% |
| Q3 2018 | $81,000 | – | 500 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Evolutionary Tree Capital Management, LLC | 68,937 | $5,138,000 | 3.04% |
| Avoro Capital Advisors LLC | 2,150,000 | $160,240,000 | 2.77% |
| Casdin Capital, LLC | 550,000 | $40,992,000 | 1.22% |
| TOBAM | 371,107 | $27,659,000 | 1.18% |
| Ikarian Capital, LLC | 455,900 | $33,978,000 | 1.14% |
| Eventide Asset Management | 697,156 | $51,959,000 | 0.77% |
| FOX RUN MANAGEMENT, L.L.C. | 4,902 | $365,000 | 0.66% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 31,500 | $2,348,000 | 0.62% |
| Sivik Global Healthcare LLC | 20,000 | $1,491,000 | 0.54% |
| Rock Springs Capital Management LP | 328,750 | $24,502,000 | 0.54% |